The Inflammatory Cell Death in Diabetic Kidney Disease: Integrating Multifactorial Mechanisms into Novel Therapeutics
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262211033 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Bin Fang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Inflammation, Cell Death. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Key Research and Development Program of Hubei Province.
Abstract (Originalsprache)
In addition to apoptosis, inflammatory cell death modalities—including pyroptosis, necroptosis, ferroptosis, NETosis, and the integrated paradigm of PANoptosis—are now established as critical drivers of diabetic kidney disease (DKD) pathogenesis. This review summarizes how key inflammatory cell death molecular mediators—such as the NLRP3 inflammasome, the RIPK1/RIPK3/MLKL axis, executioner caspases, and gasdermin-D (GSDMD)—orchestrate the death of renal cells (podocytes, tubular cells, mesangial cells, endothelium), thereby propagating inflammation and fibrosis. Preclinical studies have demonstrated the efficacy of agents targeting these pathways, highlighting their therapeutic potential. Key challenges include achieving cell type-specific targeting, overcoming redundancy among cell death pathways, and improving the translational applicability of current models. Emerging solutions include the development of precise biomarkers, kidney-targeted delivery systems, and combination therapies that concurrently target multiple cell death axes. This review synthesizes evidence establishing inflammatory cell death as a cornerstone of DKD pathology and provides a conceptual framework to guide future research and therapeutic innovation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
ORCID-Profile: Sijia Du, Fangfang He, Chun Zhang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Key Research and Development Program of Hubei Province
- National Key Research and Develop-ment Program of China
Zitieren
APA
Fang, B., Huang, W., Du, S., Hao, Y., He, F., & Zhang, C. (2025). The Inflammatory Cell Death in Diabetic Kidney Disease: Integrating Multifactorial Mechanisms into Novel Therapeutics. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262211033
Vancouver
Fang B, Huang W, Du S, Hao Y, He F, Zhang C. The Inflammatory Cell Death in Diabetic Kidney Disease: Integrating Multifactorial Mechanisms into Novel Therapeutics. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262211033
BibTeX
@article{Fang2025,
author = {Fang, Bin and Huang, Wei and Du, Sijia and Hao, Yu and He, Fangfang and Zhang, Chun},
title = {The Inflammatory Cell Death in Diabetic Kidney Disease: Integrating Multifactorial Mechanisms into Novel Therapeutics},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262211033}
}
EUVIMED